MAPT and Alzheimer disease: Furthermore, focusing on studying AD-specific biomolecules such as Aβ, hyperphosphorylated tau protein, and specific miRNAs (e.g., miR-193b and miR-125b-5p), which are associated with AD, can reduce the impact of heterogeneity and increase analysis specificity [82].